English
Español
Français
Português
Русский
简体中文
Dr. Michael H. Gold is the founder and medical director of Gold Skin Care Center, Advanced Aesthetics Medical Spa, The Laser & Rejuvenation Center, and Tennessee Clinical Research Center in Nashville, TN. He is a board-certified dermatologist and dermatologic surgeon and oversees the various facets of the center's operations — a combination of medical and surgical dermatology, cosmetic dermatology, aesthetic services and research endeavors, which began in 1990.
Dr. Gold has earned worldwide recognition for providing patients with leading-edge technological advances in dermatology and aesthetic skin care. He plays an integral role in the development of new pharmaceutical products and medical devices through his clinical research. He presents the results regularly at national and international dermatology and cosmetic meetings.
Dr. Gold has authored over 400 published scientific articles, 35 textbook chapters, and has edited two textbooks on Photodynamic Therapy. He serves on most major dermatology journal boards and is the current Editor-in-Chief of the Journal of Cosmetic Dermatology and Dermatological Reviews. Dr. Gold helped establish an annual meeting known as SCALE, or Symposium for Cosmetic Advances & Laser Education. It is one of the leading U.S. dermatologic and aesthetic meetings.
Dr. Gold also helped start two international groups: the Dermatologic Aesthetic Surgery International League (DASIL), which aims to create a global community for the open exchange of knowledge and innovation by physicians specializing in Dermatologic and Aesthetic Surgery. It has become one of the most prominent international dermatology groups. It showcases meetings all over the world; and 5-Continent-Congress (5CC), is one of the world’s leading conferences on Dermatologic and Aesthetic Surgery, where he is the current President of the Congress.
Energy-based technologies: The future of skin rejuvenation - (in collaboration with 5CC and DASIL)
ChairEnergy-based technologies: The future of skin rejuvenation - (in collaboration with 5CC and DASIL)
IPL Technology – What We Know From Research from Long-Term AnalysesCosmeceuticals: Nutrition & nutraceuticals for skin aging - Balancing risks and benefits!
ChairEXOCOBIO Symposium - Exosome Industry Creator with 53+ Scientific Publications : Exosome Therapy Cases from Resistance to Significant Response
What Makes ASCE Different?EXOCOBIO Symposium - Exosome Industry Creator with 53+ Scientific Publications : Exosome Therapy Cases from Resistance to Significant Response
Q&ALa Tribune - The Economic Forum - (Part 2)
ModeratorBoNTA: The revolution that lasts - (in collaboration with PSAD)
New Toxins in the US – What is Making its Way Through the Clinical Trial Domain in 2026Peels, mesotherapy and needling - Contributed talks
Microneedling RF in 2026 – What Have We Learned- Demostración en vivo – Tercio superior facial
Chair- Moldeo corporal – Avances del IMCAS World Congress
Contorno corporal y tratamientos de reducción de grasa en 2026 – qué hay de nuevo y qué funciona con EBD e inyectables- Toxinas – Avances del Congreso Mundial IMCAS (en colaboración con 5CC)
Moderador- Toxinas – Avances del Congreso Mundial IMCAS (en colaboración con 5CC)
Panorama de toxinas: USA- Más allá de los exosomas & PRP – Reinicio celular
Nuevas actualizaciones sobre exosomas – en ee. uu. y en el exterior – qué hay de nuevo y qué es real- Dermatología Clínica - Acné 360°: tratamientos hormonales, tópicos y procedimientos
Tratamientos del acné vulgar con láseres y EBDs en 2026- Dermatología Clínica - cicatriz por cicatriz ( en colaboración con Keloid Research Foundation)
El uso de EBDs en el tratamiento de cicatrices hipertróficas y queloides- Regenerativo – Células madre, exosomas y biológicos
Exosomes - What's Behind Their Rapid Explosion into Regenerative Medicine?Descubra IMCAS Academy
¿Necesita ayuda?